Search Within

Sergio Andres Giralt

  1. "Craig Moskowitz"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (5)
Groups
  1. Bone Marrow Transplant (25)
  2. Center for Hematologic Malignancies (25)
  3. Department of Medicine (25)
  4. Hematologic Malignancies, Division of (25)
  5. Lymphoma (23)
  6. Survivorship Research (22)

More Groups

People
  1. Craig Moskowitz (25)
  2. Craig Sauter (21)
  3. Matthew Matasar (16)
  4. Miguel-Angel Perales (12)
  5. Parastoo Dahi (11)
  6. Sean Devlin (11)

More People

Years
  1. 2019 (2)
  2. 2018 (3)
  3. 2017 (3)
  4. 2016 (3)
  5. 2015 (6)
  6. 2014 (6)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (12)
  2. Blood (10)
  3. British Journal of Haematology (1)
  4. Hematological Oncology (1)
  5. Journal of Clinical Oncology (1)
Publishers
  1. Elsevier Inc. (12)
  2. American Society of Hematology (10)
  3. American Society of Clinical Oncology (1)
  4. John Wiley & Sons (1)
  5. Wiley Blackwell (1)

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of revaccination after autologous hematopoietic stem cell transplantation in lymphoma patients with or without rituximab exposure
    Meeting Abstract

    Preston, E. V.; Palazzo, M.; Seier, K.; Maloy, M. A.; Devlin, S. M.; Giralt, S. A.; Scordo, M.; Dahi, P. B.; Matasar, M. J.; Moskowitz, C. H.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
    Journal Article

    Sauter, C. S.; Senechal, B.; Rivière, I.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Singh, A. N.; Szenes, V. Z.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Transformed indolent lymphoma outcomes similar to de novo diffuse large B-cell lymphoma after autologous hematopoietic stem cell transplantation (AHCT), but not allogeneic HCT (allo-HCT)
    Meeting Abstract

    Pathak, P.; Shah, G. L.; Tsyvkin, E.; Maloy, M.; Knezevic, A.; Devlin, S. M.; Giralt, S. A.; Matasar, M. J.; Moskowitz, C. H.; Sauter, C. S.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Toxicities associated with high dose chemotherapy and autologous stem cell transplantation in older patients with non-Hodgkin lymphoma
    Meeting Abstract

    Dahi, P. B.; Rondon Clavo, C.; Maloy, M.; Seier, K.; Devlin, S. M.; Robinson, K.; Scordo, M.; Shah, G. L.; Tamari, R.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Early toxicities associated with radiation based conditioning for relapsed/refractory Hodgkin lymphoma patients undergoing high dose therapy and autologous stem cell transplantation (HDT-ASCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Devlin, S. M.; Yahalom, J.; Matasar, M. J.; Moskowitz, A.; Giralt, S. A.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • A Phase I trial of 19-28z CAR-T cells post-high dose therapy and autologous transplantation (HDT-ASCT) for relapsed and refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Sauter, C.; Riviere, I.; Senechal, B.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Moskowitz, C.; Giralt, S.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • A comprehensive assessment of toxicities in patients with central nervous system lymphoma undergoing autologous stem cell transplantation using thiotepa, busulfan, and cyclophosphamide conditioning
    Journal Article

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L. M.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of <= 12 months
    Journal Article

    Lunning, M. A.; Migliacci, J. C.; Hilden, P.; Devlin, S. M.; Castro-Malaspina, H.; Giralt, S.; Perales, M. A.; Zelenetz, A. D.; Moskowitz, C. H.; Sauter, C. S.
    British Journal of Haematology (2016)

    Fulltext@MSK | Save
  • Outcomes of diffuse large B-cell lymphoma (DLBCL) patients progressing after autologous hematopoietic stem cell transplant
    Meeting Abstract

    Gil-Cupello, M.; Shah, G. L.; Maloy, M. A.; Goldman, D. A.; Devlin, S. M.; Matasar, M. J.; Giralt, S. A.; Sauter, C. S.; Moskowitz, C. H.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save